Transplant Medications and Simulect

People who have had a kidney transplant typically receive anti-rejection medications, such as Simulect® (basiliximab), to prevent transplant rejection. Simulect is given within two hours after kidney transplant surgery, and again four days later. It works by binding to certain white blood cells and preventing them from attacking the newly transplanted organ.
Simulect is specifically used to help prevent acute kidney rejection, which is rejection that occurs within the first six months of receiving a donor kidney. It is approved for use in adults and children as young as one year old.
(For more details, click Simulect Uses. This Web page offers a closer look at how this medication works to prevent transplant rejection, and also lists some of Simulect's unapproved uses.)
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.